MYC and cancer: Our results demonstrate the crucial role of RTKs/RAS/RAF/c-Myc signaling in dictating ferroptotic death, and suggest that malignant mutations in this signaling pathway could predict the responsiveness of cancer cells to future ferroptosis-inducing therapies.